1-6 of 6
Chang Gon Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Chang Gon Kim, Min Hee Hong, Dahee Kim, Brian Hyohyoung Lee, Hyunwook Kim, Chan-Young Ock, Geoffrey Kelly, Yoon Ji Bang, Gamin Kim, Jung Eun Lee, Chaeyeon Kim, Se-Heon Kim, Hyun Jun Hong, Young Min Park, Nam Suk Sim, Heejung Park, Jin Woo Park, Chang Geol Lee, Kyung Hwan Kim, Goeun Park, Inkyung Jung, Dawoon Han, Jong Hoon Kim, Junha Cha, Insuk Lee, Mingu Kang, Heon Song, Chiyoon Oum, Seulki Kim, Sukjun Kim, Yoojoo Lim, Seunghee Kim-Schulze, Miriam Merad, Sun Och Yoon, Hyun Je Kim, Yoon Woo Koh, Hye Ryun Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (10): 2097–2110.
https://doi.org/10.1158/1078-0432.CCR-23-3249
Published: 15 May 2024
View article titled, A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma
Open the PDF for A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Phase II Clinical Trial of Eribulin–Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma

Chang Gon Kim, Nam Suk Sim, Jeong Eun Kim, Kum-Hee Yun, Young Han Lee, Seung Hyun Kim, Wooyeol Baek, Yoon Dae Han, Sang Kyum Kim, Jee Hung Kim, Yoon Woo Koh, Inkyung Jung, Su-Jin Shin, Sun Young Rha, Jin-Hee Ahn, Hyo Song Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (15): 3225–3234.
https://doi.org/10.1158/1078-0432.CCR-22-0518
Published: 02 August 2022
View article titled, Phase II Clinical Trial of Eribulin–Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma
Open the PDF for Phase II Clinical Trial of Eribulin–Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma in another window
Includes: Supplementary data
Journal Articles

Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma

Seok-Young Kim, Sang-Min Kim, Sumin Lim, Ji Yeon Lee, Su-Jin Choi, San-Duk Yang, Mi Ran Yun, Chang Gon Kim, Seo Rin Gu, Chaewon Park, A-Young Park, Sun Min Lim, Seong Gu Heo, HyunKi Kim, Byoung Chul Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (15): 4397–4409.
https://doi.org/10.1158/1078-0432.CCR-20-5026
Published: 01 August 2021
View article titled, Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma
Open the PDF for Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma

Hyunsoo Cho, Kyung Hwan Kim, Hoyoung Lee, Chang Gon Kim, Haerim Chung, Yoon Seok Choi, Su-Hyung Park, June-Won Cheong, Yoo Hong Min, Eui-Cheol Shin, Jin Seok Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (10): 2947–2958.
https://doi.org/10.1158/1078-0432.CCR-20-3418
Published: 15 May 2021
View article titled, Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma
Open the PDF for Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors

Minsuk Kwon, Chang Gon Kim, Hoyoung Lee, Hyunsoo Cho, Youngun Kim, Eung Chang Lee, Seong Jin Choi, Junsik Park, In-Ho Seo, Bjarne Bogen, Ik-Chan Song, Deog-Yeon Jo, Jin Seok Kim, Su-Hyung Park, Inhak Choi, Yoon Seok Choi, Eui-Cheol Shin
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (7): 1644–1655.
https://doi.org/10.1158/1078-0432.CCR-19-0267
Published: 01 April 2020
View article titled, PD-1 Blockade Reinvigorates Bone Marrow CD8<sup>+</sup> T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors
Open the PDF for PD-1 Blockade Reinvigorates Bone Marrow CD8<sup>+</sup> T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors in another window
Includes: Supplementary data
Journal Articles

Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8+ T Cells is Determined by Their Differentiation Status in Glioblastoma

Junsik Park, Minsuk Kwon, Kyung Hwan Kim, Tae-Shin Kim, Seon-Hui Hong, Chang Gon Kim, Seok-Gu Kang, Ju Hyung Moon, Eui Hyun Kim, Su-Hyung Park, Jong Hee Chang, Eui-Cheol Shin
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (8): 2549–2559.
https://doi.org/10.1158/1078-0432.CCR-18-2564
Published: 15 April 2019
View article titled, Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8<sup>+</sup> T Cells is Determined by Their Differentiation Status in Glioblastoma
Open the PDF for Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8<sup>+</sup> T Cells is Determined by Their Differentiation Status in Glioblastoma in another window
Includes: Supplementary data